The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase III KEYNOTE-181 study.
 
Takashi Kojima
No Relationships to Disclose
 
Kei Muro
No Relationships to Disclose
 
Eric Francois
No Relationships to Disclose
 
Chih-Hung Hsu
No Relationships to Disclose
 
Toshikazu Moriwaki
No Relationships to Disclose
 
Sung-Bae Kim
No Relationships to Disclose
 
Se-Hoon Lee
No Relationships to Disclose
 
Jaafar Bennouna
No Relationships to Disclose
 
Ken Kato
No Relationships to Disclose
 
Shen Lin
No Relationships to Disclose
 
Shi-Qui Qin
No Relationships to Disclose
 
Paula Ferreira
No Relationships to Disclose
 
Toshihiko Doi
No Relationships to Disclose
 
Antoine Adenis
No Relationships to Disclose
 
Peter C. Enzinger
No Relationships to Disclose
 
Manish A. Shah
No Relationships to Disclose
 
Ruixue Wang
No Relationships to Disclose
 
Pooja Bhagia
No Relationships to Disclose
 
S. Peter Kang
No Relationships to Disclose
 
Jean-Philippe Metges
No Relationships to Disclose